Opiant

Orexo AB

This pharmaceutical company develops improved medications and digital therapies for patients with opioid use disorder, cancer pain and insomnia.

Amygdala Neurosciences

This biopharmaceutical company develops oral enzyme inhibitors to treat substance use disorders by reducing cravings and preventing relapse in patients.

Sobrera Pharma

This pharmaceutical company develops medical treatments for patients suffering from alcohol use disorder and other addiction-related conditions.

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

Enabling psychedelics-assisted therapies

This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.

Latigo Biotherapeutics

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.

Pleo Pharma

This pharmaceutical company develops oral treatments to mitigate cannabis withdrawal symptoms for adult patients with cannabis use disorder.

Centessa Pharmaceuticals

The company develops orexin receptor agonists for patients with sleep-wake disorders, neurological conditions and neuropsychiatric diseases.